Helicobacter Pylori causes iron deficiency and also anemia even without the presence of an ulcer

January 13, 2006

According to a recent analysis of 7,462 Americans, having a Helicobacter Pylori infection increases your risk of being deficient in iron and increases your risk of developing anemia. The bacterium Helicobacter Pylori causes stomach inflammation and is responsible for most ulcers. It is also a major cause of MAST cell lymphoma and other stomach cancers. The bacterium increases the risk of iron deficiency 1.4 fold, and iron deficiency anemia by 2.6 fold. The subjects did not need to have a peptic ulcer to develop H pylori associated anemia. The survey analysis is published in the january 15th, 2006 issue of the American journal of Epidemiology.

Recent research with vitamin D shows that it is low in the elderly with osteoporosis and also in the elderly with hip fractures. Having sufficient vitamin D reduces the risk of falling in the elderly, reduces the risk of osteoporosis, reduces the risk of fracture, and has been shown to improve strength.

Mice were exposed to either a close to lethal dose of X-ray radiation or injected with a very high dosage of the cancer chemotherapeutic drug carboplatin. Both cause myelosuppression or decreased ability to create red blood cells, white blood cells and platelets. This is due to a suppression of bone marrow activity and the cells in the bone marrow that create different kinds of blood cells. This leads to a decreased ability to fight infection among other things. 4 to 6 hours after the radiation or drug exposure the mice were supplemented by Goji Berry as an injection at differing potencies for 6 days. All doses of Goji Berry ameliorated to some degree a drop in white blood cells caused by the drug, all doses significantly ameliorated the reduction in red blood cells caused by chemotherapy, and all doses significantly ameliorated the drop in platelets caused by the chemotherapy drug. In the case of radiation exposure, all doses significantly ameliorated a drop in white blood cells, all doses helped ameliorate the drop in red blood cells, and the larger doses ameliorated the drop in platelets caused by radiation exposure. The study is published in the April 20th, 2005 issue of the journal Cancer Biotherapy and Radiopharmaceuticals.